26 results
424B5
VANI
Vivani Medical Inc
5 Mar 24
Prospectus supplement for primary offering
11:31am
pandemic and macroeconomic factors that could impact our business, such as supply chain and inflationary pressures and the effects of the Russian … , interruptions or other adverse
effects to clinical trials and patient enrollment; delays in regulatory review; manufacturing and supply chain interruptions
DEFR14A
VANI
Vivani Medical Inc
1 May 23
Revised proxy
4:49pm
, quality systems, manufacturing, supply chain, product development, formulation, and IT. From 2009 to 2011, Mr. Le was the Chief Operating Officer
DEFM14A
fq8ji6gq96lh5x
24 Jun 22
Proxy related to merger
4:44pm
424B3
wzigp0r dyx6u8
24 Jun 22
Prospectus supplement
4:38pm
S-4/A
4ppc45xsibkf
16 Jun 22
Registration of securities issued in business combination transactions (amended)
5:23pm
S-4
gczdws6y lrz20fso63q
13 May 22
Registration of securities issued in business combination transactions
5:10pm
424B5
qrsqx1i8s4
23 Jun 21
Prospectus supplement for primary offering
12:26pm
424B5
vp7uc
22 Jun 21
Prospectus supplement for primary offering
5:23pm
424B3
wnfm pumom8wh4in
28 Apr 21
Prospectus supplement
9:49pm